Although similar phenotypically, there is evidence that male and female breast cancer differ
in their molecular landscapes. In this systematic review, we consolidated all existing …

Abstract Treatment with therapy targeting BRAF and MEK (BRAF/MEK) has revolutionized
care in melanoma and other cancers; however, therapeutic resistance is common and …

Simple Summary Most breast cancers co-express estrogen receptor α (ERα) and
progesterone receptor (PgR). These cancers are sensitive to endocrine therapy and, in …

Breast Cancer (BC) is a heterogeneous disease and the most prevalent malignant tumor in
women worldwide. The majority of BC cases are positive for Estrogen Receptor (ER) and …

Breast cancer is often seen as a disease that occurs in women, but it can also appear in men
in a very small percentage, below 1%. Men have a minimal amount of breast tissue …

Males account for 1% of all cases of breast cancer. With the aging of the world's population,
the disease has exhibited a rise in incidence in recent decades. Male breasts are smaller …

Background The purpose of this study was to explore a new estrogen receptor (ER) and/or
progesterone receptor (PR)+ and human epidermal growth factor receptor 2 (HER2)− breast …

Introduction To report a rare case of male breast micropapillary carcinoma (MBMC) with
early metastasis of axillary lymph nodes, the molecular characteristics were further studied …

Mężczyźni stanowią 1% wszystkich przypadków raka piersi. Wraz ze starzeniem się
populacji na świecie w ostatnich dekadach odnotowuje się wzrost przypadków tego …

Estrogen receptor α (ERα) and progesterone receptor (PgR) are crucial prognostic and
predictive biomarkers that are usually co-expressed in breast cancer (BC). However, 12 …